Clinical trial
Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone
NCT00376259 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00376259 |
|---|---|
| Title | Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone |
| Official title | An Open-label, Multicenter, Randomized Study of Combination Therapy With Oral LDT600 (Telbivudine) Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-positive Patients With Chronic Hepatitis B Who Are Lamivudine Resistant |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Drug |
| Interventions | telbivudine, adefovir dipivoxil |
| Enrollment | 43 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2008 |
| First posted | Sep 14, 2006 |
| Last update posted | Jun 30, 2011 |
| Countries | Hong Kong, South Korea, Taiwan, Thailand, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: